Cogent Biosciences, Inc.
COGT
$39.16
$0.180.46%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 390.89M | 237.85M | 245.66M | 287.08M | 335.52M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.35M | 7.16M | 7.22M | 9.40M | 6.01M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 397.24M | 245.01M | 252.88M | 296.47M | 341.53M |
|
|
|||||
| Total Current Assets | 397.24M | 245.01M | 252.88M | 296.47M | 341.53M |
| Net Property, Plant & Equipment | 23.87M | 24.95M | 26.05M | 26.56M | 27.60M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.82M | 4.86M | 4.86M | 4.86M | 4.86M |
| Total Assets | 425.93M | 274.82M | 283.80M | 327.90M | 384.02M |
|
|
|||||
| Total Accounts Payable | 16.03M | 16.63M | 14.15M | 12.01M | 15.06M |
| Total Accrued Expenses | 43.23M | 38.87M | 33.07M | 83.89M | 36.16M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.71M | 1.66M | 1.61M | 1.57M | 1.52M |
| Total Finance Division Other Current Liabilities | 1.29M | 1.27M | 484.00K | 373.00K | 306.00K |
| Total Other Current Liabilities | 1.29M | 1.27M | 484.00K | 373.00K | 306.00K |
| Total Current Liabilities | 62.25M | 58.42M | 49.32M | 55.71M | 53.05M |
|
|
|||||
| Total Current Liabilities | 62.25M | 58.42M | 49.32M | 55.71M | 53.05M |
| Long-Term Debt | 44.25M | 43.95M | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 14.60M | 15.05M | 15.48M | 15.90M | 16.31M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.37M | 2.36M | 5.00K | -- | -- |
| Total Liabilities | 123.47M | 119.78M | 64.80M | 71.61M | 69.36M |
|
|
|||||
| Common Stock & APIC | 1.28B | 1.05B | 1.04B | 1.00B | 994.72M |
| Retained Earnings | -1.09B | -1.00B | -931.47M | -859.48M | -791.56M |
| Treasury Stock & Other | 208.00K | 13.00K | 164.00K | 447.00K | 896.00K |
| Total Common Equity | 194.55M | 47.12M | 110.83M | 145.69M | 204.06M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 107.92M | 107.92M | 108.17M | 110.60M | 110.60M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 107.92M | 107.92M | 108.17M | 110.60M | 110.60M |
|
|
|||||
| Total Common Equity | 194.55M | 47.12M | 110.83M | 145.69M | 204.06M |
| Total Preferred Equity | 107.92M | 107.92M | 108.17M | 110.60M | 110.60M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 302.46M | 155.04M | 219.00M | 256.29M | 314.66M |
|
|
|||||